Galunisertib Combined With Capecitabine in Advanced CRC With PM

NCT05700656 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer Metastatic
Peritoneal Carcinomatosis

Interventions

DRUG: Galunisertib plus capecitabine

Sponsor

The Netherlands Cancer Institute

Collaborators

[object Object]